Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder
- 15 May 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (10) , 3410-3421
- https://doi.org/10.1158/1078-0432.ccr-03-0134
Abstract
Purpose: Expression profiling by DNA microarray technology permits the identification of genes underlying clinical heterogeneity of bladder cancer and which might contribute to disease progression, thereby improving assessment of treatment and prediction of patient outcome.Keywords
This publication has 48 references indexed in Scilit:
- Evaluation of gene expression measurements from commercial microarray platformsNucleic Acids Research, 2003
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Identifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Computational analysis of microarray dataNature Reviews Genetics, 2001
- Microarray profiling of gene expression patterns in bladder tumor cells treated with genisteinJournal of Biomedical Science, 2001
- The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladderBritish Journal of Urology, 1996